Protein-protein interaction network analysis of major depression disorder via proteomic approach from cerebrospinal fluid sample

References

• 1.
  Ghorbani R. Effects of cognitive therapy, drug therapy and combined therapy in improvement of major depression. Koomesh 2011; 13: 114-119.
• 2.
  Bot M, Chan MK, Jansen R, Lamers F, Vogelzangs N, Steiner J, et al. Serum proteomic profiling of major depressive disorder. Transl Psychiatry 2015; 5: 1-9.
• 3.
  Martins-de-Souza D, Guest P, Harris L, Vanattou-Saifoudine N, Webster M, Rahmoune H, Bahn S. Identification of proteomic signatures associated with depression and psychotic depression in post-mortem brains from major depression patients. Transl Psychiatry 2012; 2: 1-13.
• 4.
  Hamet P, Tremblay J. Genetics and genomics of depression. Metabolism 2005; 54: 10-15.
• 5.
  Mirmohammadkhani M. Vitamin D serum levels in nurses in Semnan educational hospitals and its association with depression. Koomesh 2016; 17: 313-322.
• 6.
  Zamanian-Azodi M, Mortazavi-Tabatabaei SA, Mansouri V, Vafaee R. Metabolite-protein interaction (MPI) network analysis of obsessive-compulsive disorder (OCD) from reported metabolites. Arvand J Health Med Sci 2016; 2: 112-120.
• 7.
  Rezaei-Tavirani M, Rahmati-Rad S, Rezaei-Tavirani M. Ethanol and cancer induce similar changes on protein expression pattern of human fibroblast cell. Iran J Pharmac Res 2016; 15: 175-184. (Persian).
• 8.
  Zali H, Zamanian-Azodi M, Tavirani MR, Baghban AA-z. Protein drug targets of lavandula angustifolia on treatment of rat Alzheimer's disease. Iran J Pharmac Res 2015; 14: 291-302.
• 9.
  Rezaie-Tavirani M, Fayazfar S, Heydari-Keshel S, Rezaee MB, Zamanian-Azodi M, Rezaei-Tavirani M, Khodarahmi R. Effect of essential oil of Rosa Damascena on human colon cancer cell line SW742. Gastroenterol Hepatol Bed Bench 2013; 6: 25-31.
• 10.
  Tohyama M, Miyata S, Hattori T, Shimizu S, Matsuzaki S. Molecular basis of major psychiatric diseases such as schizophrenia and depression. Anat Sci Int 2015; 90: 137-143.
• 11.
  Stelzhammer V, Haenisch F, Chan MK, Cooper JD, Steiner J, Steeb H, et al. Proteomic changes in serum of first onset, antidepressant drug-nave major depression patients. Int J Neuropsychopharmacol 2014; 17: 1599-1608.
• 12.
  Ditzen C, Tang N, Jastorff AM, Teplytska L, Yassouridis A, Maccarrone G, et al. Cerebrospinal fluid biomarkers for major depression confirm relevance of associated pathophysiology. Neuropsychopharmacology 2012; 37: 1013-1025.
• 13.
  Schutzer SE, Liu T, Natelson BH, Angel TE, Schepmoes AA, Purvine SO, et al. Establishing the proteome of normal human cerebrospinal fluid. PLoS One 2010; 5: e10980.
• 14.
  Zamanian-Azodi M, Rezaei-Tavirani M, Rahmati-Rad S, Hasanzadeh H, Rezaei Tavirani M, Seyyedi SS. Protein-protein interaction network could reveal the relationship between the breast and colon cancer. Gastroenterol Hepatol Bed Bench 2015; 8: 215-224.
• 15.
  Ranjbar MM, Ahmadi NA, Ghorban K, Ghalyanchi Langeroudi A, Dadmanesh M, Amini H-R, Sedighi Moghaddam B. Immnoinformatics: novel view in understanding of immune system function, databases and prediction of immunogenic epitopes. Koomesh 2015; 17: 18-26.
• 16.
  Safaei A, Rezaei Tavirani M, Arefi Oskouei A, Zamanian Azodi M, Mohebbi SR, Nikzamir AR. Protein-protein interaction network analysis of cirrhosis liver disease. Gastroenterol Hepatol Bed Bench 2016; 9: 114-123.
• 17.
  Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 2003; 13: 2498-2504.
• 18.
  Szklarczyk D, Franceschini A, Wyder S, Forslund K, Heller D, Huerta-Cepas J, et al. STRING v10: proteinprotein interaction networks, integrated over the tree of life. Nucleic Acids Res 2015; 43: D447-452.
• 19.
  Bader GD, Hogue CW. An automated method for finding molecular complexes in large protein interaction networks. BMC Bioinformatics 2003; 4: 1-27.
• 20.
  Bindea G, Mlecnik B, Hackl H, Charoentong P, Tosolini M, Kirilovsky A, et al. ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics 2009; 25: 1091-1093.
• 21.
  Bindea G, Galon J, Mlecnik B. Cluepedia cytoscape plugin: pathway insights using integrated experimental and in silico data. Bioinformatics 2013; 29: 661-663.
• 22.
  Sayehmiri K. Is there a relationship between metabolic syndrome and depression? A systematic review and meta-analysis. Koomesh 2015; 16: 488-494.
• 23.
  Puchades M, Hansson SF, Nilsson CL, Andreasen N, Blennow K, Davidsson P. Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimer's disease. Brain Res Mol Brain Res 2003; 118: 140-146.
• 24.
  Lim J, Hao T, Shaw C, Patel AJ, Szab G, Rual JF, et al. A proteinprotein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration. Cell 2006; 125: 801-814.
• 25.
  Lage K, Karlberg EO, Strling ZM, Olason PI, Pedersen AG, Rigina O, et al. A human phenome-interactome network of protein complexes implicated in genetic disorders. Nature Biotechnol 2007; 25: 309-316.
• 26.
  Yang Y, Wan C, Li H, Zhu H, La Y, Xi Z, et al. Altered levels of acute phase proteins in the plasma of patients with schizophrenia. Anal Chem 2006; 78: 3571-3576.
• 27.
  Small SA, Petsko GA. Retromer in Alzheimer disease, parkinson disease and other neurological disorders. Nat Rev Neurosci 2015; 16: 126-132.
• 28.
  Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nature Genet 2009; 41: 1088-1093.
• 29.
  Zamanian-Azodi M, Rezaei-Tavirani M, Nejadi N, Arefi Oskouie A, Zayeri F, Hamdieh M, et al. Serum proteomic profiling of obsessive-compulsive disorder (OCD), washing subtype: a preliminary study. Basic Clin Neur J (Persian)##.